Peak Bio, Inc.

Peak Bio, Inc. is the operating name associated with Ignyte Acquisition Corp, trading under the ticker IGNY, a blank-check company that completed its initial public offering in 2021. Sponsored by Ignyte Sponsor LLC, the SPAC targets the healthcare and biopharmaceutical sector, with Peak Bio representing a clinical-stage oncology-focused company identified as its proposed business combination partner. The 10-Q filing submitted November 15, 2021, with accession number 0001206774-21-002746, reflects the company's quarterly reporting obligations during its active SPAC lifecycle. For full filing history, merger timeline, shareholder vote details, and real-time status updates on IGNY and thousands of other SPACs, sign up for SpacDesk at spacdesk.com.